A Pharmacokinetic Substudy of the TDE-PH-304 Protocol

NCT01934582 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: UT-15C SR
DRUG: treprostinil diethanolamine

Sponsor

United Therapeutics